Cargando…
Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment
Autores principales: | Ortolani, Federica, Piccinno, Elvira, Grasso, Valeria, Papadia, Francesco, Panzeca, Rossana, Cortese, Claudio, Felappi, Barbara, Tummolo, Albina, Vendemiale, Marcella, Barbetti, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877418/ https://www.ncbi.nlm.nih.gov/pubmed/26239141 http://dx.doi.org/10.1007/s00592-015-0793-1 |
Ejemplares similares
-
Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report
por: Tummolo, Albina, et al.
Publicado: (2018) -
Living with phenylketonuria in adulthood: The PKU ATTITUDE study
por: Cazzorla, Chiara, et al.
Publicado: (2018) -
Effectiveness of Automated Insulin Management Features of the MiniMed(®) 640G Sensor-Augmented Insulin Pump
por: Zhong, Alex, et al.
Publicado: (2016) -
Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017) -
Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
por: Schiavon, Michele, et al.
Publicado: (2014)